Systolic Hypertension Clinical Trial
Official title:
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
The purpose of the study is to evaluate dose response of blood pressure lowering for 4 doses of AHU377, given once daily (50 mg, 100 mg, 200 mg and 400 mg) in combination with a fixed dose of valsartan (320 mg).
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05086523 -
Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study
|
Phase 1/Phase 2 | |
| Completed |
NCT00151229 -
Valsartan in Elderly Isolated Systolic Hypertension Study
|
Phase 4 | |
| Recruiting |
NCT04755764 -
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
|
||
| Completed |
NCT03712033 -
TEC4Home Stroke - Feasibility of Home Telemonitoring Technology in Managing Hypertension Among Stroke/TIA Patients
|
||
| Completed |
NCT00940966 -
A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT06084065 -
Feasibility and Effectiveness of a Ring-type Blood Pressure Measurement Device
|
N/A | |
| Recruiting |
NCT02032719 -
Improved Self Management in Uncontrolled Systolic Hypertension
|
Phase 3 | |
| Completed |
NCT01755572 -
Blood Pressure Outcomes With Liraglutide Therapy
|
Phase 4 |